-
Bristol-Myers Squibb and CytomX Therapeutics Extend Worldwide Collaboration to Discover Probody? The
americanpharmaceuticalreview
March 21, 2017
Bristol-Myers Squibb Company and CytomX Therapeutics, Inc., a biopharmaceutical company developing investigational Probody therapeutics for the treatment of cancer...
-
Crown Bioscience Appoints GM
contractpharma
March 20, 2017
Thatte to head up the company's center of excellence in San Diego
-
Threshold Pharmaceuticals and Molecular Templates Agree to Combine
americanpharmaceuticalreview
March 20, 2017
The transaction will result in a combined company focused on the development of novel treatments for cancer.
-
AZ’ Lynparza hits targets in ovarian cancer trial
pharmatimes
March 17, 2017
AstraZeneca has unveiled data from a late-stage trial showing that Lynparza improved progression free survival (PFS) in ...
-
Angsana’s RNA-based fusions cancer panel selected for Ignyta’s STARTRK2 clinical trial in Asia-Pacif
pharmaasia
March 16, 2017
Angsana Molecular & Diagnostics to partner with molecular test laboratory for STARTRK-2 clinical trial sites in Asia working with Ignyta.
-
US nod for Novartis’ breast cancer drug Kisqali
pharmatimes
March 15, 2017
Novartis’ selective cyclin-dependent kinase inhibitor Kisqali has been approved by the US Food and Drug Administration...
-
Hodgkin Lymphoma Survivors Face Risk of Second Cancer: Study
drugs.com
March 14, 2017
The risk of developing a second type of cancer may be high among Hodgkin lymphoma survivors, especially those with a family history of cancer.
-
Cancer clinic turns to crowdfunding to boost therapy access
pharmaceutical-technology
March 14, 2017
A cancer clinic based in London has taken the unprecedented step of launching a crowdfunding appeal striving to raise ...
-
Bavarian Nordic, Roche to test bladder cancer combo
pharmaceutical-technology
March 14, 2017
Roche and Bavarian Nordic have unveiled plans to assess the former’s anti-PD-L1 antibody Tecentriq in combination with ...
-
Cure Found for Cancer Killing Endangered Tasmanian Devils
drugs.com
March 13, 2017
Immunotherapy seems to cure endangered Tasmanian devils of a deadly disease, a new study indicates.
ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
Pharma Sources Insight July 2025
